Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia
Pharmacyclics LLC.
Meletios A Dimopoulos; Alessandra Tedeschi; Judith Trotman; Ramón García-Sanz; David Macdonald; Veronique Leblond; Beatrice Mahe; Charles Herbaux; Constantine Tam; Lorella Orsucci; M Lia Palomba; Jeffrey V Matous; Chaim Shustik; Efstathios Kastritis; Steven P Treon; Jianling Li; Zeena Salman; Thorsten Graef; Christian Buske